Prudence A. Russell

12.4k total citations · 1 hit paper
53 papers, 1.8k citations indexed

About

Prudence A. Russell is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Prudence A. Russell has authored 53 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Prudence A. Russell's work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Diagnosis and Treatment (16 papers) and Lung Cancer Research Studies (12 papers). Prudence A. Russell is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Diagnosis and Treatment (16 papers) and Lung Cancer Research Studies (12 papers). Prudence A. Russell collaborates with scholars based in Australia, United States and Switzerland. Prudence A. Russell's co-authors include Gavin Wright, Zoe Wainer, Matthew Conron, Marissa Daniels, Richard A. Williams, Stephen B. Fox, Benjamin Solomon, Thomas John, Marzena Walkiewicz and Wendy A. Cooper and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Prudence A. Russell

53 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

2011 473 citations Prudence A. Russell, Zoe Wainer et al. Journal of Thoracic Oncology profile →

Peers

Countries citing papers authored by Prudence A. Russell

Since Specialization

Citations

This map shows the geographic impact of Prudence A. Russell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prudence A. Russell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prudence A. Russell more than expected).

Fields of papers citing papers by Prudence A. Russell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prudence A. Russell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prudence A. Russell. The network helps show where Prudence A. Russell may publish in the future.

Co-authorship network of co-authors of Prudence A. Russell

This figure shows the co-authorship network connecting the top 25 collaborators of Prudence A. Russell. A scholar is included among the top collaborators of Prudence A. Russell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prudence A. Russell. Prudence A. Russell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival 2020 ·Lung Cancer ·Puey Ling Chia, Sagun Parakh, Prudence A. Russell, Hui Gan, (unknown), Val Gebski, Carmel Murone, Marzena Walkiewicz, Zhanqi Liu, Bibhusal Thapa, Fiona E. Scott, Andrew M. Scott, Thomas John	11
2	Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort 2020 ·Lung Cancer ·Puey Ling Chia, Prudence A. Russell, (unknown), Bibhusal Thapa, Val Gebski, Carmel Murone, Marzena Walkiewicz, Ulf Eriksson, Andrew M. Scott, Thomas John	10
3	OA08.05 Quantifying Tumour Infiltrating Lymphocytes (TILs) in Malignant Pleural Mesothelioma (MPM) -Defining the Hot, the Warm and the Cold Tumours. 2018 ·Journal of Thoracic Oncology ·Bibhusal Thapa, (unknown), Gareth Rivalland, Carmel Murone, (unknown), Stephen Barnett, Simon Knight, Shona Hendry, Prudence A. Russell, Thomas John	1
4	Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma 2017 ·Molecular Cancer Therapeutics ·Clare E. Weeden, Aliaksei Z. Holik, Richard J. Young, Stephen Ma, (unknown), Stephen B. Fox, Phillip Antippa, Louis Irving, Daniel Steinfort, Gavin Wright, Prudence A. Russell, Matthew E. Ritchie, Christopher J. Burns, Benjamin Solomon, Marie-Liesse Asselin-Labat	19
5	Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non–Small Cell Lung Cancer 2017 ·Clinical Cancer Research ·Wendy A. Cooper, Prudence A. Russell, (unknown), Edwina Duhig, (unknown), Peter J. Jessup, Christine Khoo, Connull Leslie, Annabelle Mahar, David Moffat, (unknown), Céline Faure, (unknown), Amanda Grattan, Stephen B. Fox	100
6	P2.01-047 Intra- and Inter-Observer Reproducibility Study of PD-L1 Biomarker in Non-Small Cell Lung Cancer (NSCLC) - The DREAM STUDY 2017 ·Journal of Thoracic Oncology ·Wendy A. Cooper, Prudence A. Russell, (unknown), (unknown), Edwina Duhig, (unknown), Peter J. Jessup, Christine Khoo, Connull Leslie, Annabelle Mahar, David Moffat, (unknown), Amanda Grattan, (unknown), (unknown), (unknown)	1
7	IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis 2016 ·Cancer Research ·(unknown), Louise McLeod, Sultan Alhayyani, Alistair Miller, Prudence A. Russell, Walter Ferlin, Stefan Rose‐John, Saleela M. Ruwanpura, Brendan J. Jenkins	95
8	Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations 2015 ·Pathology ·Timothy Clay, Prudence A. Russell, Hoang Dang Khoa, Vijaya Sundararajan, Matthew Conron, Gavin Wright, Alexander Dobrovic, Melissa M. Moore, Sue‐Anne McLachlan	12
9	Genomic Characterisation of Small Cell Lung Cancer Patient-Derived Xenografts Generated from Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Specimens 2014 ·PLoS ONE ·Tracy L. Leong, Kieren D. Marini, Fernando J. Rossello, (unknown), Prudence A. Russell, Zdenka Prodanovic, Beena Kumar, Vinod Ganju, Muhammad Alamgeer, Louis Irving, Daniel Steinfort, Craig D. Peacock, Jason E. Cain, Anette Szczepny, D. Neil Watkins	26
10	Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients 2013 ·Journal of Thoracic Oncology ·Prudence A. Russell, Stephen Barnett, Marzena Walkiewicz, Zoe Wainer, Matthew Conron, Gavin Wright, Julian Gooi, Simon Knight, Rochelle Wynne, Danny Liew, Thomas John	97
11	Intravenous leiomyomatosis with intracardiac extension – A review of diagnosis and management with an illustrative case 2013 ·Surgical Oncology ·Timothy Clay, (unknown), Orla McNally, Prudence A. Russell, Andrew Newcomb, Andrew Wilson	61
12	EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinoma 2013 ·Pathology ·Prudence A. Russell, (unknown), (unknown), Timothy Clay, Melissa M. Moore, Gavin Wright, Matthew Conron, Zoe Wainer, Alexander Dobrovic, Sue‐Anne McLachlan	2
13	The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer 2013 ·Thorax ·Muhammad Alamgeer, Vinod Ganju, Anette Szczepny, Prudence A. Russell, Zdenka Prodanovic, Beena Kumar, Zoe Wainer, Tracey J. Brown, Michal Schneider, Matthew Conron, Gavin Wright, D. Neil Watkins	57
14	Recurrent Myocarditis—An Important Mimic of Ischaemic Myocardial Infarction 2013 ·Heart Lung and Circulation ·Bo Xu, V. Michael Jelinek, James Hare, Prudence A. Russell, David L. Prior	6
15	The Role of Cancer-Testis Antigens as Predictive and Prognostic Markers in Non-Small Cell Lung Cancer 2013 ·PLoS ONE ·Thomas John, Maud H. W. Starmans, Yao‐Tseng Chen, Prudence A. Russell, Stephen Barnett, Shane White, Paul Mitchell, Marzena Walkiewicz, Arun Azad, Philippe Lambin, Ming‐Sound Tsao, Siddhartha Deb, Nasser K. Altorki, Gavin Wright, Simon Knight, Paul C. Boutros, Jonathan Cebon	38
16	Sex and SUVmax: Sex-Dependent Prognostication in Early Non–Small Cell Lung Cancer 2012 ·Journal of Nuclear Medicine ·Zoe Wainer, Marissa Daniels, Jason Callahan, David Binns, Rodney J. Hicks, Phillip Antippa, Prudence A. Russell, Naveed Alam, Matthew Conron, Benjamin Solomon, Gavin Wright	8
17	Interobserver agreement in determining non-small cell lung cancer subtype in specimens acquired by EBUS-TBNA 2012 ·European Respiratory Journal ·Daniel Steinfort, Prudence A. Russell, Alpha Tsui, (unknown), Gavin Wright, Louis Irving	34
18	Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification breakdown → 2011 ·Journal of Thoracic Oncology ·Prudence A. Russell, Zoe Wainer, Gavin Wright, Marissa Daniels, Matthew Conron, Richard A. Williams	473
19	Subacute Anthracycline Cardiotoxicity 2005 ·Heart Lung and Circulation ·(unknown), Prudence A. Russell, Paul A. Gould, David M. Kaye	14
20	Interstitial pneumonitis associated with sirolimus: a dilemma for lung transplantation 2003 ·The Journal of Heart and Lung Transplantation ·(unknown), Bronwyn Levvey, Prudence A. Russell, David Milne, Greg Snell	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact